Rifamycins inhibit human neutrophil functions: New derivatives with potential antiinflammatory activity

Inflammation

Volumn 21, Issue 4, 1997, Pages 391-400

  Spisani, Susanna ^a   Traniello, Serena ^a   Martuccio, Concetta ^b   Rizzuti, Olivia ^a   Cellai, Luciano ^b  

^a Dipartimento di Biochimica   (Italy)

^b Ist Strutturistica Chim G   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; RIFAMYCIN; RIFAMYCIN B; RIFAMYCIN DERIVATIVE; RIFAMYCIN S; SUPEROXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL MOTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGRANULATION; DOSE RESPONSE; DRUG EFFECT; ENZYME RELEASE; HUMAN; HUMAN CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; RESPIRATORY BURST; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS; CELL DEGRANULATION; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; HUMANS; NEUTROPHILS; RESPIRATORY BURST; RIFAMYCINS;

EID: 0030984514     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027314419843     Document Type: Article

References (22)

1. BRUFANI, M. 1977. In Topics in Antibiotics Chemistry (Ed. Sammes PC), pp 91-217. Ellis Horwood Ldt. Chichester.
2. BARTOLUCCI, C., L. CELLAI, P. DI FILIPPO, M. A. IANNELLI, A. L. SEGRE, M. BRUFANI, L. FILOCAMO, A. D. BIANCO, M. GUISO, V. BRIZZI, A. BENEDETTO, and A. DI CARD. 1993. Rifamycins as inhibitors of HIV-1. Pharm Pharmacol Lett 3:1-4.
3. TOMIYAMA, T., S. ASANO, Y. SUWA, T. MORITA, K. KATAOKA, H. MORI, and N. ENDO. 1994. Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem Biophis Res Commun 204:76-83.
4. TRAXLER, P., W. KUMP, K. MUELLER, and W. TOSH. 1990. Hypolipidemic activity of rifamycin derivatives. J. Med. Chem. 33:552-560.
5. CARUSO, I., N. PRINCIPI, G. D'URBINO, S. SANTANDREA, L. BOCCASSINI, F. MONTRONE, P. PUTTINI, A. BOMBACI, and A. BOZZATO. 1993. Rifamycin SV administered by intra-articular infiltrations shows disease modifying activity in patients with pauci- or polyarticular juvenile rheumathoid arthritis. J. Int. Med. Res. 21:243-256.
6. CARUSO, I., S. SANTANDREA, P. PUTTINI, F. MONTRONE, L. BOCCASSINI, V. AZZOLINI, M. CAZZOLA, and D. DELL'ACQUA, 1992. Prevention of appearance of radiological lesions in early rheumatoid arthritis, a randomized single-blind study comparing intra-articular rifamycin with auranofin. J. Int. Med. Res. 1:61-77.
7. PAUNESCU, E. 1970. In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin. Nature 228:1188-1190.
8. ARRIGONI-MARTELIL, E., P. SCHIATTI, and D. SELVA. 1971. Rifampicin and alanosine inhibition of adjuvant arthritis in rats. Pharm. Res. Commun. 3:239-245.
9. MARCHESONI, A., L. SINIGAGLIA, R. RANZA, M. VARENNA, N. BATTAFARANO, and S. TOSI. 1993. Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. Scand. J. Rheumatol. 22:194-198.
10. GABRIEL, S. E., D. L. CONN, and H. LUTHRA. 1990. Rifampicin therapy in rheumatoid arthritis. J. Rheumatol 17:163-166.
11. LINDBLAD, S., E. HEDFORS, and A. S. MALMBORG. 1985. Rifamycin SV in local treatment of synovitis, a clinical, arthroscopic and pharmacologic evaluation. J. Rheumatol. 12:900-903.
12. MALECH, H. L., and M. D. GALLIN. 1987. Neutrophils in human diseases. N. Engl. J. Med. 317:687-694.
13. BARTOLUCCI, C. L., CELLAI, C. MARTUCCIO, A. ROSSI, SEGRE, A. L., S. RIZEA-SAVU, and L. SILVESTRO. 1996. Synthesis of glycosylrifamycins, a new type of semisynthetic rifamycins. Helv. Chim. Acta. 79:1611-1619.
14. MAGGI, N., and R. PALLANZA. 1967. 3-(S-substituted) thiorifamycins: synthesis and antibacterial properties. Farmaco 22:307-315.
15. ZIGMOND, S. H., and J. G. HIRSCH. 1973. Leukocyte locomotion and chemotaxis: new method for evaluation and demonstration of a derived chemotactic factor. J. Exp. Med. 137:387-410.
16. GAVIOLI, R., S. SPISANI, A. L. GIULIANI, E. COSULICH, A. RISSO, and S. TRANIELLO. 1991. CD16 and CR3 receptors distinguished between the two mechanisms of tumor cytotoxicity in neutrophils. British J. Haematol. 79:387-410.
17. BIAGI, G. L., A. M. BARBARO, M. F. GAMBA, and M. C. GUERRA. 1969. Partition data of penicillins determined by means of reversed-phase thin-layer chromatography. J. Chromatogr. 41:371-379.
18. VERGNAUD, S., M. H. PACHET, C. MARTEL, G. BATROT, and F. MOREL. 1996. The cytosolic activation complex of the superoxide generating NADPH oxidase from Epstein Barr virus immortalized B lymphocytes. Eur. J. Haematol. (Suppl) 59:7.
19. MIESEL, R. D., SANOCKA, M. KURPISZ, and H. KROGER. 1995. Antiinflammatory effects of NADPH oxidase inhibitors. Inflammation 19:347-362.
20. SPISANI, S., L. DOVIGO, G. CORAZZA, R. CARLETTI, and S. TRANIELLO. 1992. The effect of rifamycin SV on neutrophil functions in patients with rheumatoid arthritis. Scand. J. Rheum. 11:65-69.
21. EGGLETON, P. L., WANG, J. PENHALLOW, N. CRAWFORD, and K. A. BROWN. 1995. Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. Ann. Rheum. Dis. 54:916-923.
22. TOMIYAMA, T., A. SHOJI, K. KATAOKA, Y. SUWA, S. ASANO, H. KANEKO, and N. ENDO. 1996. Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 271:6839-6844.